Antitumor effects of interferon and poly ICLC, and their possible utility as anti-neoplastic agents in man.
D000818:Animals; D000970:Antineoplastic Agents; D002266:Carboxymethylcellulose Sodium / Q000627:therapeutic use* / Q000031:analogs & derivatives; D002455:Cell Division / Q000187:drug effects; D002648:Child; D002986:Clinical Trials as Topic; D006801:Humans; D007372:Interferons / Q000627:therapeutic use*; D007822:Laryngeal Neoplasms / Q000628:therapy; D007938:Leukemia / Q000628:therapy; D008223:Lymphoma / Q000628:therapy; D008545:Melanoma / Q000628:therapy; D008747:Methylcellulose / Q000031:analogs & derivatives*; D051379:Mice; D009101:Multiple Myeloma / Q000628:therapy; D009369:Neoplasms / Q000628:therapy*; D009374:Neoplasms, Experimental / Q000628:therapy; D012516:Osteosarcoma / Q000628:therapy; D010212:Papilloma / Q000628:therapy; D010455:Peptides / Q000627:therapeutic use*; D011070:Poly I-C / Q000627:therapeutic use*; D011107:Polylysine / Q000627:therapeutic use* / Q000031:analogs & derivatives
D000970:Antineoplastic Agents; D010455:Peptides; D011107:Polylysine; C019531:poly ICLC; D008747:Methylcellulose; D007372:Interferons; D002266:Carboxymethylcellulose Sodium; D011070:Poly I-C